Metraipolis › archive › dc_78aa53e2ebf4

Effect of empagliflozin with or without carvedilol on tricuspid regurgitation and right ventricular remodeling: PROVE trial — Europe PMC PMID:42736580

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42736580
DOI
10.1186/s44348-[numero omesso]-4
License (as archived)
solo-consultazione
Archived
2026-10-10T02:57:41.221Z
SHA-256 of the archived text
5918e94e65eefef0c658832ea79741418232a7082bd799681b000ad293e1b419
Stable URL of this page
https://metraipolis.com/documento/dc_78aa53e2ebf4

How to cite

Effect of empagliflozin with or without carvedilol on tricuspid regurgitation and right ventricular remodeling: PROVE trial — Europe PMC PMID:42736580 — Europe PMC (en), https://europepmc.org/article/MED/42736580 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_78aa53e2ebf4 (Metraipolis archive dc_78aa53e2ebf4, sha256 5918e94e65eefef0c658832ea79741418232a7082bd799681b000ad293e1b419)
BibTeX
@misc{dc78aa53e2ebf4,
  title = {Effect of empagliflozin with or without carvedilol on tricuspid regurgitation and right ventricular remodeling: PROVE trial — Europe PMC PMID:42736580},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42736580},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_78aa53e2ebf4; sha256 5918e94e65eefef0c658832ea79741418232a7082bd799681b000ad293e1b419},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42736580. Agents can read the archived copy with the MCP tool read_document.